Table of Contents
Showcasing Value Propositions for Investors
The Malaysia healthcare outlook addresses the investment opportunities across various segments. The study explores the developments in the hospital industry, IVD and POCT industry, pharmaceutical industry, biotechnology industry, medical devices industry, connected health industry, and the aged care industry in the country. The study explores opportunities for new investors and segregates Malaysia into potential, growing and nascent market, after taking into consideration past investment, policies, trends of new investment and other growth factors (socio-economy, technology, etc). The study will give insights to investors who plan to enter the Malaysian market, as well as help the existing manufacturers to look understand the competition.
Methodology and Scope
This research service focuses on the Malaysian healthcare industry, providing a detailed overview of the investment scenario in particular. A brief overview of the tendering process, incentives for investors, and the distributor network has also been included.
This study does broadly discuss the revenue or financial forecasting of the healthcare industry, but does not address the companies which are involved with R&D or services in details.
Company profiles of those companies that are currently or imminently prominent and or may be of interest for investors in Malaysia, have been included.
The information contained in this research service was derived from published sources including the following—Government of Malaysia websites, healthcare companies’ websites, World Health Organization data, World Bank data, International Monetary Fund data and press releases, public sources, the internal data bank of Frost & Sullivan, and industry key opinion leaders (KOLs). Primary and secondary research methodologies were used to gather and analyze the data, presented in this study.
Research Scope and Objectives
The aim of this research service is to assess, analyse, and evaluate the healthcare industry in Malaysia and to provide strategic recommendations for new investors entering the market and for already existing investors to sustain their market share
The main objective of this research service is to establish an understanding of the key segments (healthcare services, connected health, medical devices, pharmaceuticals and biotechnology, and aged care), as well as to provide insights on competitors and investment pockets in Malaysia.
In-depth analysis of the Malaysian healthcare industry using primary research (manufacturers, hospitals, and clinics), secondary research, and Frost & Sullivan in-house data. The Frost & Sullivan forecasting model uses historical growth, drivers, and restraints to project the future market size. All figures are in US Dollars. The exchange rate used for any conversion is:
$1 = MYR
This research covers the overall healthcare industry in Malaysia.
Key Questions This Study Will Answer
What does the Malaysian healthcare industry offer?
What are the segments in healthcare which are growing? What are the three major concerns?
What are the major drivers and restraints in the market?
Why is Malaysia an investor’s destination?
What are the strategic recommendations for an investor?
What is the brand visibility of Malaysia as a healthcare industry?
What is the value proposition for the investor?
How is the competitive environment? Which are the major companies ruling the road?
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
The global healthcare IT market is expected to grow at a CAGR of 15.9% from 2016 to 2021 and reach USD 280.25 billion. Growing need to manage regulatory compliance through healthcare IT solutions, government ...
The ultrasound market is expected to reach USD 6.86 billion by 2021 at a CAGR of 5.2% during 2016-2021. North America and Europe held the largest share of the market in 2016; however, the Asia-Pacific ...
EU5 Computed Tomography (CT) Systems Market Outlook to 2022 Summary GlobalData’s new report, "EU5 Computed Tomography (CT) Systems Market Outlook to 2022", provides key market data on the EU5 Computed ...